Back to News
Market Impact: 0.18
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now
Source: 247wallst.com
Capital Returns (Dividends / Buybacks)Healthcare & BiotechCompany FundamentalsAnalyst Insights
Pfizer's 5.91% dividend yield is presented as the primary investment support, while renewed investor interest in its drug pipeline is cited as a source of upside. The article signals a bullish valuation view through a 24/7 Wall St. price target, but provides no target price, pipeline milestones, or financial estimates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
PFE0.48
More News
- Rhode Island sues Meta over alleged tolerance for scam advertising
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- PG&E’s CEO says AI is ‘the best thing that could’ve ever happened to the grid’
- Defense giant Saab sees orders triple after Gripen fighter jet deal with Ukraine
- Volvo Cars shares plunge 25% amid China sales slump and fresh job cuts
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%